홈

Invited Speakers

검색

Day 1 – April 10 (Thu)

[EW] IMKASID 2025 Education Workshop - What's Happening Inside an Expert's Clinic? April 10 (Thu), 13:00-14:30 | Room C
  • Comprehensive Fecal Testing: Occult Blood and Beyond
     Seung Wook Hong University of Ulsan
    Korea
  • Mastering Bowel Preparation: From Initial Challenges to Rescue Strategies for Optimal Cleansing
     Kyeong Ok Kim Yeungnam University
    Korea
  • Mastering IBD Diagnosis: Key Insights and Differential Diagnosis
     Julajak Limsrivilai Mahidol University
    Thailand
  • Objectives in the Treatment of IBD: Strategic Goals and Our Armamentarium
     Hyuk Yoon Seoul National University
    Korea

Day 1 – April 10 (Thu)

[RW1] KASID Research Workshop 1 - Recent Advances in Colorectal Carcinogenesis: Incorporating Them into Our Research April 10 (Thu), 13:00-14:30 | Meeting Room 1
  • Microbiome and Metabolic Profiling in Colorectal Adenomatous Polyposis: Unveiling Hereditary Boundaries
     Eun Mi Song Ewha Womans University
    Korea
  • Exploring the Relationship Between Host Genetics, Microbiome and Colorectal Polyposis
     Minhye Shin Inha University
    Korea
  • Unlocking Secrets: Tips for Implementing Intestinal Organoids in Colorectal Polyposis Research
     Toshiro Sato Keio University
    Japan

Day 1 – April 10 (Thu)

[RW2] KASID Research Workshop 2 - Microbiome and Host Interction: Insights into Intestinal Disease and Therapeutic Innovations (Kor) April 10 (Thu), 13:00-14:30 | Meeting Room 2
  • Microbiome and Intestinal Immunologic Disorder: New Insights with GVHD Study
    Seung Bum Lee University of Ulsan
    Korea
  • Revolutionizing Gut Health: The Current Landscape and Future of Fecal Microbiota Transplantation
     Jae-Ho Shin Kyungpook National University
    Korea

Day 1 – April 10 (Thu)

[RW3] KASID Research Workshop 3 - Hot Topics in Diet and Nutrition for IBD Patients April 10 (Thu), 15:00-16:30 | Meeting Room 1
  • Ultra-Processed Food and Risk of IBD: is it a Real Big Threat?
     Emma Halmos Monash University
    Australia
  • Osteosarcopenia in IBD: Clinical Implication and Therapeutic Perspectives
     Young Joo Yang Hallym University
    Korea
  • Discussant
     Hee Seok Moon Chungnam National University
    Korea
  • Discussant
     Seong-Eun Kim Ewha Womans University
    Korea

Day 1 – April 10 (Thu)

[RW4] KASID Research Workshop 4 - ASUC in Focus: Therapeutic Breakthroughs and Research Implications April 10 (Thu), 15:00-16:30 | Meeting Room 2
  • Evolving Role of JAK Inhibitors in ASUC: From Rescue Therapy to Early Intervention
    Robert Gilmore Mater Hospital Brisbane
    Australia
  • Korean National ASUC Cohort Registry: Preliminary Data and Future Research Potential
     Dong Hyun Kim Chonnam National University
    Korea

Day 2 – April 11 (Fri)

[BM1] Breakfast with Master 1 - Paradigm Shift of Bowel Preparation Agent April 11 (Fri), 07:30-08:00 | Meeting Room 1+2
  • Low Volume Agent: Solution vs Tablet
     Jae Myung Cha Kyung Hee University
    Korea

Day 2 – April 11 (Fri)

[KJJS] KASID-JSIBD Joint Symposium - Managing Difficult Clinical Scenarios in IBD April 11 (Fri), 08:30-10:00 | Room A
  • Integrated Endoscopic and Medical Approaches for Crohn's Strictures
     Rintaro Moroi Tohoku University Hospital
    Japan
  • Surgical Timing in IBD: A Surgeon's Perspective on Balancing Risks and Benefits
     Eun Jung Park University of Ulsan
    Korea
  • How to Monitor and Manage Pouchitis in UC with Pouchoscopy
     Shintaro Akiyama University of Tsukuba
    Japan
  • Challenges in Patients with Concurrent IBD and Cancer
     Yoo Jin Lee Keimyung University
    Korea

Day 2 – April 11 (Fri)

[RF] RAPID Forum - First Steps to Tackling Inflammatory Bowel Disease and Colorectal Cancer in Asia April 11 (Fri), 08:30-10:00 | Room B
  • Uneven Rise: Are Inflammatory Bowel Disease Incidences Growing Equally Across Asia?
     Luan Minh Dang University Medical Center
    Vietnam
  • Compromising with Limited Options: Strategies for Treating Inflammatory Bowel Disease in Asia
     Soo-Young Na The Catholic University of Korea
    Korea
  • Rising Tide: Are Asian Countries Facing a Surge in Colorectal Cancer Cases?
     Alex Hwong-Ruey Leow Pantai Hospital Kuala Lumpur
    Malaysia
  • Colorectal Cancer Screening Strategies in Asia: Insights from Pioneering Countries
     Su Young Kim Yonsei University
    Korea

Day 2 – April 11 (Fri)

[KIJS] KASID-KAI Joint Symposium - Leaky Gut in Health and GI Disorders (Kor) April 11 (Fri), 08:30-10:00 | Room C
  • Leaky Gut: Mechanisms and Clinical Implications in Humans
     Seong-Joon Koh Seoul National University
    Korea
  • NFAT5 Dictates Crosstalk between Intestinal Epithelial Cell Differentiation and Microbiota
    Donghyun Kim Seoul National University
    Korea
  • Interplay of Microbe-Epithelia-Immune System in Leaky Gut
     Kyung Ku Jang Yonsei University
    Korea

Day 2 – April 11 (Fri)

[SY1] Symposium 1- Future Horizons in IBD Treatment: Innovations and Emerging Therapies April 11 (Fri), 10:20-11:50 | Room A
  • Emerging IBD Drugs and Future Directions
     Fernando Magro University of Porto
    Portugal
  • Treatment Sequencing in Advanced IBD Therapies
     Won Moon Kosin University
    Korea
  • Optimizing Immunomodulator Use in the New Biologic Era
     Shinichiro Shinzaki Hyogo Medical University
    Japan

Day 2 – April 11 (Fri)

[KGJS] KASID-GEST Joint Symposium - One Step Forward: New Screening Methods and Strategies to Prevent Colorectal Cancer April 11 (Fri), 10:20-11:50 | Room B
  • Colonoscopy-Based Colorectal Cancer Screening: Pros and Cons
     Jae Myung Cha Kyung Hee University
    Korea
  • How to Apply FIT for Precision Colorectal Cancer Screening
     Wen-Feng Hsu National Taiwan University Hospital
    Taiwan
  • Metabolic Risk Factors: Their Role in Screening and Preventing Colorectal Cancer
     Chen-Ya Kuo Fu Jen Catholic University Hospital
    Taiwan
  • Can Liquid Biopsy replace Fecal Test for Colorectal Cancer Screening?
     Hyeong-Ho Jo Daegu Catholic University
    Korea

Day 2 – April 11 (Fri)

[SY2] Symposium 2 - Bench to Bedside: Novel Diagnostics and Therapeutics of Colorectal Cancer April 11 (Fri), 10:20-11:50 | Room C
  • Patient-derived Organoids in Colorectal Cancer: Where are We Now?
    Toshiro Sato Keio University
    Japan
  • Pathogenesis and Emerging Targets of Mucinous Colorectal Cancer
     Jae-Il Park MD Anderson Cancer Center
    USA
  • Human Microbiome as Adjunctive Therapeutic in Colorectal Cancer
     Sang Sun Yoon Yonsei University
    Korea

Day 2 – April 11 (Fri)

[LS1] Luncheon Symposium 1 - Patient centric IBD treatment strategies for IBD April 11 (Fri), 12:00-12:40 | Room A
  • How to Incorporate the Shared Decision Making into the Clinical Practice?
     Manasi Agrawal Icahn School of Medicine at Mount Sinai
    USA
  • Assembling the Future through Upadacitinib: Creating a Better Everyday in IBD
     Sang Hyoung Park University of Ulsan
    Korea

Day 2 – April 11 (Fri)

[LS2] Luncheon Symposium 2 - What are the Treatment Strategies for IBD? April 11 (Fri), 12:00-12:40 | Room B
  • Managing Pregnancy in Patients with Inflammatory Bowel Disease: Tips for Improving Safety and Outcomes
     Sung Wook Hwang University of Ulsan
    Korea
  • The Current Treatment for IBD: Switching to Biosimilar in Patients with IBD
     Taku Kobayashi Kitasato University
    Japan

Day 2 – April 11 (Fri)

[LS3] Luncheon Symposium 3 - Bridging the Gap in IBD Management:
Optimizing Treatment with Vedolizumab April 11 (Fri), 12:00-12:40 | Room C
  • Navigating CD Therapy: Tips to Optimize Your Treatment Options with Vedolizumab Experience
     Peter Bossuyt Imelda GI Clinical Research Center
    Belgium
  • Leveraging UC Long-Term Outcomes with Vedolizumab & VERDICT trial to Determine Optimal UC Treatment Target Trough AI
     Hyuk Yoon Seoul National University
    Korea

Day 2 – April 11 (Fri)

[LS4] Luncheon Symposium 4 - Step Toward Remission Through Subcutaneous Infliximab April 11 (Fri), 12:40-13:20 | Room A
  • Optimizing Therapeutic Outcomes in IBD: Evidence Update on Subcutaneous Infliximab Administration
     Chang Hwan Choi Chung-Ang University
    Korea
  • New approach to Subcutaneous Infliximab: Compared to SC Standard Therapy
     Sung Noh Hong Sungkyunkwan University
    Korea

Day 2 – April 11 (Fri)

[LS5] Luncheon Symposium 5 - Advancing IBD Treatment with Xelenka April 11 (Fri), 12:40-13:20 | Room B
  • Biosimilars for the Management of IBD: Economic Considerations
     Jae Hee Cheon Yonsei University
    Korea
  • The Maximizing Benefits of Biosimilars in IBD: Lessons Learned from the Real-life Cases with Xelenka
     Dong Hoon Baek Pusan National University
    Korea

Day 2 – April 11 (Fri)

[LS6] Luncheon Symposium 6 - Optimizing Outcomes in Ulcerative Colitis: Integrating Ozanimod into Treatment Paradigms Optimizing Treatment with Vedolizumab
April 11 (Fri), 12:40-13:20 | Room C
  • Positioning of Zeposia in UC Treatment Paradigm: Strategic Insights from Long-term Experience
     Micheal Chiorean Swedish Medical Center
    USA
  • Practical Use and Real World Experience of Zeposia for Korean Patients
    Jun Lee Chosun University
    Korea

Day 2 – April 11 (Fri)

[SY3] Symposium 3 - Key Questions in CRC Screening and Surveillance April 11 (Fri), 13:50-15:20 | Room A
  • Clinically Significant Serrated Polyps: Risk Factors, Detection, Resection, and Surveillance of Real Threats
     Seth D Crockett Oregon Health & Science University
    USA
  • AI for Colonoscopy: How to Use It in the Real World?
     Jung Ho Bae Seoul National University
    Korea
  • Cost-Effectiveness of Colonoscopy for Screening: What Matters Most?
     Fumiaki Ishibashi International University of Health and Welfare
    Japan

Day 2 – April 11 (Fri)

[SY4] Symposium 4 - Advances in Dietary and Nutritional Management in Intestinal Disease April 11 (Fri), 13:50-15:20 | Room B
  • Personalized Nutrition in IBD: Challenges and Opportunities
    Emma Halmos Monash University
    Australia
  • Reassessing Low FODMAP Diet for Irritable Bowel Syndrome: New Insights and Applications
    Seong-Eun Kim Ewha Womans University
    Korea
  • Dietary Factors Associated with Early Onset Colorectal Neoplasms
     Jinhee Hur Sungkyunkwan University
    Korea

Day 2 – April 11 (Fri)

[SY5] Symposium 5 - Gut Microbiota in Health and GI Diseases: From Homeostasis to Chaos April 11 (Fri), 13:50-15:20 | Room C
  • Interplay between Diet, Microbiome, and Metabolome in IBD
     Minhu Chen Sun Yat-sen University
    China
  • Role of Mycobiome and Virome in IBD: Do Minorities Have a Major Impact?
     Jae Hee Cheon Yonsei University
    Korea
  • Targeting Gut Microbiome for IBD Treatment: From Concept to Clinical Reality
     Harry Sokol Sorbonne University, Saint-Antoine Hospital
    France

Day 2 – April 11 (Fri)

[SY6] Symposium 6 - Multidisciplinary Approach to Challenging Cases April 11 (Fri), 15:40-17:10 | Room A

Day 2 – April 11 (Fri)

[RW5] KASID Research Workshop 5 - I: Integrating Intestinal Ultrasound in Korea: Global, Domestic, and Educational Perspectives April 11 (Fri), 15:40-16:30 | Meeting Room 3
  • Intestinal Ultrasound Worldwide: Costs, Insurance, and Practitioners
     June Hwa Bae Daegu Catholic University
    Korea
  • Challenges and Opportunities for Intestinal Ultrasound in Korea: IBD and Beyond
     Jeongkuk Seo Chung-Ang University
    Korea
  • Strategies for Popularizing Intestinal Ultrasound: Educational Approaches
     Jihye Park Yonsei University
    Korea

Day 2 – April 11 (Fri)

[RW5] KASID Research Workshop 5 - II: Stepping Toward the Global Standard in Intestinal Ultrasound April 11 (Fri), 16:30-17:10 | Meeting Room 3
  • Toward the Global Standard with Standardized Documentation
     Shin Ju Oh Kyung Hee University
    Korea
  • Multicenter Studies in Intestinal Ultrasound: Collaborative Research
     Sung Wook Hwang University of Ulsan
    Korea

Day 3 – April 12 (Sat)

[BM2] Breakfast with Master 2 - Evolving IBD Care with Vaccination April 12 (Sat), 07:30-08:00 | Meeting Room 1+2
  • A Deep Dive into Shingles Prevention for IBD Patients
     TBD

Day 3 – April 12 (Sat)

[SY7] Symposium 7 - Precision Medicine in IBD April 12 (Sat), 08:30-10:00 | Room A
  • Precision Biomarkers in IBD: Revolutionizing Personalized Treatment
     Raja Atreya University Hospital Erlangen
    Germany
  • Advancing IBD Histology: Integrating Precision Histology in IBD Management
     So-Woon Kim Kyung Hee University
    Korea
  • Precision medicine, Uncovering the Risk Factors in IBD: Genes, Microbiome, and Environment
     Manasi Agrawal Icahn School of Medicine at Mount Sinai
    USA

Day 3 – April 12 (Sat)

[SY8] Symposium 8 - Latest Updates on Small Bowel Disease April 12 (Sat), 08:30-10:00 | Room B
  • Small Bowel Ulcers: Differential Diagnosis for Crohn’s Disease
     Takayuki Matsumoto Iwate Medical University
    Japan
  • Diagnostic Approach to Small Bowel Tumors: A Case-Based Discussion
     Eun Ran Kim Sungkyunkwan University
    Korea
  • Recent Updates in Small Bowel Endoscopy: New Devices and Indications
     Han Hee Lee The Catholic University of Korea
    Korea

Day 3 – April 12 (Sat)

[SY9] Symposium 9 - AI-Driven Transformation in Intestinal Disease Care April 12 (Sat), 08:30-10:00 | Room C
  • AI Endoscopy and IBD: A Peek Into the Future
     Peter Bossuyt Imelda GI Clinical Research Center
    Belgium
  • Application of AI Models in Diagnosis of Intestinal Diseases
     Young-Gon Kim Seoul National University
    Korea
  • Innovative Use of Large Language Models as Medical Chatbots for Intestinal Diseases
     Dennis Shung Yale School of Medicine
    USA

Day 3 – April 12 (Sat)

[ND] Nurse and Dietitian Session] Best IBD Care: Nursing, Nutrition, and Treatment April 12 (Sat), 10:15-11:35 | Room C
  • The Role of Nurses in Quality Care of IBD
     Shin Ae Lee Severance Hospital
    Korea
  • Crohn’s Disease Exclusion Diet
     So hyun Park Eunpyeong St. Mary’s Hospital
    Korea
  • Understanding Adverse Events Related to the IBD Medications
     Hyo-Yeop Song Wonkwang University
    Korea
  • Issues in Health Insurance for Advanced Therapies
     Dong Hoon Baek Pusan National University
    Korea

Day 3 – April 12 (Sat)

[LS7] Luncheon Symposium 7 - New and Now: A Deep Dive into Ustekinumab for IBD Patients April 12 (Sat), 12:25-13:05 | Room A
  • Recent Update for the Treatment of Fibrostenosing Small Bowel Crohn’s Disease
     Takayuki Matsumoto Iwate Medical University
    Japan
  • Role of Ustekinumab for Patients in Bio-na?ve Ulcerative Colitis with the Long-Term Perspective
     Seong-Joon Koh Seoul National University
    Korea

Day 3 – April 12 (Sat)

[LS8] Luncheon Symposium 8 - The Most Experienced JAK-i, Tofacitinib in UC pfizer April 12 (Sat), 12:25-13:05 | Room B
  • Optimizing Tofacitinib Use in Ulcerative Colitis: Insights from Real-World Evidence
     Eun Soo Kim Kyungpook National University
    Korea
  • Deep Dive into the Safety of Tofacitinib
     Eun Mi Song Ewha Woman University
    Korea

Day 3 – April 12 (Sat)

[LS9] Luncheon Symposium 9 - Therapeutic Approaches for Better Patient Outcomeeisaikorea April 12 (Sat), 12:25-13:05 | Room B
  • Management of UC Patients with Advanced Therapy: JAK Inhibitors’ Role
     Soo-Young Na The Catholic University of Korea
    Korea
  • Jyseleca's Role in IBD Treatment: Insights from Clinical Experience
     Shintaro Akiyama University of Tsukuba
    Japan

Day 3 – April 12 (Sat)

[LS10] Luncheon Symposium 10 - Integrative Advances in GI Therapeutics: Microbiome Insights and Optimized Treatment with 5-ASA April 12 (Sat), 13:05-13:45 | Room A
  • Expanding Horizons of Microbiome Therapeutics: C. difficile Infection and Beyond
     Philippe Pinton Ferring Pharmaceuticals
    Denmark
  • Optimizing Therapeutic Approaches & Consensus Statements in IBD Treatment
     Won Moon Kosin University
    Korea

Day 3 – April 12 (Sat)

[PS] KASID Presidential Plenary Session - Leading the Way in Intestinal Diseases April 12 (Sat), 13:55-15:35 | Room A
  • [Plenary I] Targeting Cancer Stem Cells for Prevention and Treatment of Colorectal Neoplasia: Promises and Challenges
     Tae Il Kim Yonsei University
    Korea
  • [Plenary II] Exploring Mucosal Immune Network in IBD: Translating Science to the Clinic
     Takanori Kanai Keio University
    Japan
  • [Plenary III] Disease Clearance in IBD: How Far Can We Go?
     Fernando Magro University of Porto
    Portugal
Hosted by
  • KASID
Supported by
Korea Tourism Organization
Seoul Tourism Organization
Diamond
abbvie
Jassen
SAMSUNG BIOEPIS
Takeda
Platinum
DEAWOONG
FERRING PHARMACEUTICALS
Gold
Eisasi Korea Inc.
Pfizer

Korean Association for the Study of Intestinal Diseases 31, Seolleung-ro 86 Gil, Gangnam-Gu, Seoul, 06193, Korea

IMKASID 2025 Secretariat [People-x, Inc.] 1F, Haeoreum B/D, 16, Yeoksam-ro 17-gil, Gangnam-gu, Seoul, 06246, Korea
E. info@imkasid.kr | T. 82-2-566-6031

Copyright ⓒ Korean Association for the Study of Intestinal Diseases All rights reserved